The store will continue to offer exceptional care to medical cannabis patients with a separate consultation space, retail floor, checkout area and exit for people with a valid Commonwealth of Massachusetts medical card.
Read More
The company recorded revenue of $14.9 million for the first quarter of 2019, an increase of 85% over the same quarter in 2018.
Read More
The company is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus.
Read More
The workshop was designed to help hemp farmers or those who are interested in the hemp industry learn the best pre-planting practices prior to the planting season.
Read More
The Company’s cash and cash equivalent position as of March 31, 2019 was $68.3 million.
Read More
Get stock alerts, news & related alerts straight to your inbox!